233 related articles for article (PubMed ID: 24498011)
21. Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation.
Wang NY; Wang C; Li W; Wang GJ; Cui GZ; He H; Zhao HJ
Asian Pac J Cancer Prev; 2014; 15(4):1539-44. PubMed ID: 24641364
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
23. Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.
Tamura Y; Igarashi M; Suda T; Wakai T; Shirai Y; Umemura T; Tanaka E; Kakizaki S; Takagi H; Hiasa Y; Onji M; Aoyagi Y
Dig Dis Sci; 2010 Jul; 55(7):2095-101. PubMed ID: 19731025
[TBL] [Abstract][Full Text] [Related]
24. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
25. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.
Li B; Liu A; Wen Y; Yang G; Zhao J; Li X; Mao Y; Li B
J Clin Lab Anal; 2021 Sep; 35(9):e23932. PubMed ID: 34403527
[TBL] [Abstract][Full Text] [Related]
26. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
Khien VV; Mao HV; Chinh TT; Ha PT; Bang MH; Lac BV; Hop TV; Tuan NA; Don LV; Taketa K; Satomura S
Int J Biol Markers; 2001; 16(2):105-11. PubMed ID: 11471892
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
Yamashiki N; Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Inoue K; Okamura A; Arita S; Harada K
Oncol Rep; 1999; 6(6):1229-32. PubMed ID: 10523686
[TBL] [Abstract][Full Text] [Related]
28. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma.
Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Tanaka J; Kagebayashi C; Satomura S
J Gastroenterol; 2014 Mar; 49(3):555-63. PubMed ID: 24057163
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Park SJ; Jang JY; Jeong SW; Cho YK; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Park S; Bang HI
Medicine (Baltimore); 2017 Mar; 96(11):e5811. PubMed ID: 28296720
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma.
Sassa T; Kumada T; Nakano S; Uematsu T
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1387-92. PubMed ID: 10654799
[TBL] [Abstract][Full Text] [Related]
31. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
Zhang XF; Lai EC; Kang XY; Qian HH; Zhou YM; Shi LH; Shen F; Yang YF; Zhang Y; Lau WY; Wu MC; Yin ZF
Ann Surg Oncol; 2011 Aug; 18(8):2218-23. PubMed ID: 21336512
[TBL] [Abstract][Full Text] [Related]
32. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):111-7. PubMed ID: 16431313
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
Sterling RK; Jeffers L; Gordon F; Sherman M; Venook AP; Reddy KR; Satomura S; Schwartz ME
Am J Gastroenterol; 2007 Oct; 102(10):2196-205. PubMed ID: 17617202
[TBL] [Abstract][Full Text] [Related]
36. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.
Shimauchi Y; Tanaka M; Kuromatsu R; Ogata R; Tateishi Y; Itano S; Ono N; Yutani S; Nagamatsu H; Matsugaki S; Yamasaki S; Tanikawa K; Sata M
Oncol Rep; 2000; 7(2):249-56. PubMed ID: 10671666
[TBL] [Abstract][Full Text] [Related]
37. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
38. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.
Wu CS; Lee TY; Chou RH; Yen CJ; Huang WC; Wu CY; Yu YL
PLoS One; 2014; 9(6):e99959. PubMed ID: 24927126
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Yoshida S; Kurokohchi K; Arima K; Masaki T; Hosomi N; Funaki T; Murota M; Kita Y; Watanabe S; Kuriyama S
Int J Oncol; 2002 Feb; 20(2):305-9. PubMed ID: 11788893
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.
Wang Y; Chen Y; Ge N; Zhang L; Xie X; Zhang J; Chen R; Wang Y; Zhang B; Xia J; Gan Y; Ren Z; Ye S
Ann Surg Oncol; 2012 Oct; 19(11):3540-6. PubMed ID: 22532305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]